Skip to content
Recall Observatory FDA recall evidence

Drug product

BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.

D-0540-2025

April 21, 2025

Class II

Product summary

Firm
Mckesson Medical-Surgical Inc. Corporate Office
Event
Event 97110
Status
Ongoing
Classification
Class II
Quantity
3 Vials
Official record key
drug-enforcement:D-0540-2025

Official wording

Reason: CGMP Deviations; potential temperature excursions due to transit delays

Code information: Lot: YK4W, Expiration date: 4/30/2029

Distribution pattern: Within the U.S - OH, VA, FL.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations